EXICURE, INC. Operating Leases, Rent Expense, Contingent Rentals
EXICURE, INC. (XCUR) reported Operating Leases, Rent Expense, Contingent Rentals of $298.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeasesRentExpenseContingentRentals · last filed 2020-03-10
- EXICURE, INC. operating leases, rent expense, contingent rentals for the quarter ending 2018-12-31 was $67.00K, a 36.73% increase year-over-year.
- EXICURE, INC. operating leases, rent expense, contingent rentals for the quarter ending 2018-09-30 was $67.00K, a 12.99% decline year-over-year.
- EXICURE, INC. operating leases, rent expense, contingent rentals for the quarter ending 2018-06-30 was $75.00K, a 3.85% decline year-over-year.
- EXICURE, INC. operating leases, rent expense, contingent rentals for the quarter ending 2018-03-31 was $89.00K, a 15.58% increase year-over-year.
- EXICURE, INC. operating leases, rent expense, contingent rentals for fiscal 2018 was $298.00K, a 6.05% increase from fiscal 2017.
- EXICURE, INC. operating leases, rent expense, contingent rentals for fiscal 2017 was $281.00K, a 5.64% increase from fiscal 2016.
- EXICURE, INC. operating leases, rent expense, contingent rentals for fiscal 2016 was $266.00K.
| Period end | Operating Leases, Rent Expense, Contingent Rentals 3 month | Operating Leases, Rent Expense, Contingent Rentals 6 month | Operating Leases, Rent Expense, Contingent Rentals 9 month | Operating Leases, Rent Expense, Contingent Rentals 12 month |
|---|---|---|---|---|
| 2018-12-31 | $67.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $134.00K derived: sum of 2 quarters · filed 2020-03-10 | $209.00K derived: sum of 3 quarters · filed 2020-03-10 | $298.00K 10-K · filed 2020-03-10 |
| 2018-09-30 | $67.00K 10-Q · filed 2019-11-07 | $142.00K derived: sum of 2 quarters · filed 2019-11-07 | $231.00K 10-Q · filed 2019-11-07 | $280.00K derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $75.00K 10-Q · filed 2019-08-08 | $164.00K 10-Q · filed 2019-08-08 | $213.00K derived: sum of 3 quarters · filed 2019-09-23 | $290.00K derived: sum of 4 quarters · filed 2019-09-23 |
| 2018-03-31 | $89.00K 10-Q · filed 2019-05-08 | $138.00K derived: sum of 2 quarters · filed 2019-09-23 | $215.00K derived: sum of 3 quarters · filed 2019-09-23 | $293.00K derived: sum of 4 quarters · filed 2019-09-23 |
| 2017-12-31 | $49.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-09-23 | $126.00K derived: sum of 2 quarters · filed 2019-09-23 | $204.00K derived: sum of 3 quarters · filed 2019-09-23 | $281.00K 10-K/A · filed 2019-09-23 |
| 2017-09-30 | $77.00K 10-Q · filed 2018-11-06 | $155.00K derived: sum of 2 quarters · filed 2018-11-06 | $232.00K 10-Q · filed 2018-11-06 | $307.00K derived: sum of 4 quarters · filed 2018-11-06 |
| 2017-06-30 | $78.00K 10-Q · filed 2018-08-06 | $155.00K 10-Q · filed 2018-08-06 | $230.00K derived: sum of 3 quarters · filed 2018-08-06 | $313.00K derived: sum of 4 quarters · filed 2018-08-06 |
| 2017-03-31 | $77.00K 10-Q · filed 2018-05-15 | $152.00K derived: sum of 2 quarters · filed 2018-05-15 | $235.00K derived: sum of 3 quarters · filed 2018-05-15 | |
| 2016-12-31 | $75.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $158.00K derived: sum of 2 quarters · filed 2018-03-09 | $266.00K 10-K · filed 2018-03-09 | |
| 2016-09-30 | $83.00K 10-Q · filed 2017-11-14 | $191.00K 10-Q · filed 2017-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |